Distinct lipid changes in primary biliary cholangitis may signal inflammation and fibrosis. Discover how these findings could ...
Healio spoke with Marlyn Mayo, MD, about increased research focused on symptoms of primary sclerosing cholangitis presented at The Liver Meeting, as well as treatments being ...
Content developed independently by our editors and supported by our partners. Carrington Garvin had been living the fun-packed life of a typical 21-year-old in Las Vegas—dating, working for a gaming ...
Primary sclerosing cholangitis (PSC) is a rare chronic liver disease in which the bile ducts inside and outside the liver progressively decrease in size due to inflammation and scarring. Many people ...
Acute cholangitis is diagnosed on the basis of the clinical features, supported by laboratory evidence of systemic infection. Imaging is helpful in revealing biliary obstruction and any underlying ...
The cholangitis infection is often caused by bacteria, a gallstone or any another blockage. Primary biliary cholangitis is a chronic condition where inflammation of the bile duct system keeps bile ...
(MENAFN- EIN Presswire) The Primary Biliary Cholangitis landscape is transforming-get the latest 7MM epidemiology and market insights with DelveInsight. LAS VEGAS , NV, UNITED STATES, February 10, ...
Many people with primary biliary cholangitis are not receiving recommended alkaline phosphatase monitoring. Learn more about ...
The MarketWatch News Department was not involved in the creation of this content. Primary Biliary Cholangitis (PBC) Treatment Market to Reach USD 2.72 Billion by 2033, Driven by Next-Generation FXR ...
Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Primary Biliary Cholangitis Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering. This report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback